Trials / Unknown
UnknownNCT00973336
Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Surgery?
Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Successful Surgery in Patients Without Osteoporosis?
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary Hyperparathyroidism (pHPT) increases bone turnover and resorption and thus calcium efflux out of bone. After successful surgical treatment of pHPT, bone takes up calcium again which may result in secondary hyperparathyroidism or even "hungry bone syndrome". Until today there are no studies about this problem helping to develop recommendations or guidelines how to prevent these symptoms. Study hypothesis: Calcium and vitamin D intake after surgery for PHPT protects the bone by keeping PTH in the normal range (less secondary, reactive hyperparathyroidism), prevents hungry bone- syndrome and improve bone-turnover markers (osteoporosis protection).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium and vitamin D | 1000mg calcium per day 800 IE vitamin D per day |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-01
- First posted
- 2009-09-09
- Last updated
- 2016-03-16
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT00973336. Inclusion in this directory is not an endorsement.